Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
The role of adenosine in ischemic preconditioning in different species remains controversial. Ischemic preconditioning was examined in perfused rat and rabbit hearts. In rat and rabbit hearts subjected to 30 min global normothermic ischemia followed by 30 min of reperfusion, left ventricular developed pressure (LVDP) recovered to 36 +/- 8% and 44 +/- 7% of preischemia, respectively. Pre-treatment with transient (6 min) global ischemia improved recovery of LVDP (75 +/- 7% and 82 +/- 9% pre-ischemia, respectively), and improved recovery of coronary flow and end-diastolic pressure. Effects of preconditioning were unrelated to cytosolic [ATP], but were associated with reduced ischemic acidosis, and improved post-ischemic recovery of [Mg2+], [P(i)] and delta GATP. In addition to ischemia, transient episodes of hypoxia (5% O2), norepinephrine stimulation (0.1 microM) or metabolic inhibition (5 mM cyanide minus glycolytic substrate) all improved recovery from prolonged ischemia. Microdialysis revealed that 6 min of ischemic preconditioning increased dialysate [adenosine] from 0.25 to 6.81 +/- 0.87 microM in rat hearts, and from 0.33 to 1.98 +/- 0.41 microM in rabbit hearts. Extracellular [adenosine] was also enhanced during the transient periods of hypoxia, norepinephrine stimulation and metabolic inhibition shown to be protective. Pre-treatment with 0.5 microM Nb-cyclohexyladenosine mimicked preconditioning, and 50 microM 8-(rho-sulfophenyl) theophylline attenuated ischemic preconditioning in rat and rabbit hearts. 8-(rho-sulfophenyl) theophylline also abolished effects of preconditioning on ischemic acidosis, and post-ischemic [Mg2+], [P(i)] and delta GATP. The data demonstrate that (i) preconditioning is triggered by transient periods of energy imbalance: (ii) endogenous adenosine is of primary importance in mediating the cardioprotection following a single transient ischemic stimulus in rat and rabbit hearts; and (iii) post-receptor mechanisms of this adenosine-mediated preconditioning appear to involve reduced ischemic acidosis and enhanced recovery of [P(i)], [Mg2+] and delta GATP.
Headrick
J P
JP
Department of Physiology & Pharmacology, School of Molecular Sciences, James Cook University of North Queensland, Townsville, Australia.
D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D003326:Coronary Circulation; D004734:Energy Metabolism; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D019157:Ischemic Preconditioning, Myocardial; D008274:Magnesium / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D017551:Microdialysis; D017202:Myocardial Ischemia; D015425:Myocardial Reperfusion; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D010758:Phosphorus; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D013045:Species Specificity; D013997:Time Factors; D016277:Ventricular Function, Left
D010710:Phosphates; D010725:Phosphocreatine; D010758:Phosphorus; C027513:N(6)-cyclohexyladenosine; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D008274:Magnesium; D000241:Adenosine